Weight Loss Management
Obesity is a chronic condition characterized by an excessive accumulation of body fat that poses a significant risk to an individual’s health. It is a global health concern, affecting millions of people of all ages, genders, and races.
The World Health Organization (WHO) defines obesity as having a body mass index (BMI) of 30 or higher, which is calculated by dividing an individual’s weight by the square of their height.
Obesity is linked to a range of serious health problems, including type 2 diabetes, heart disease, stroke, certain types of cancer, and depression, among others. It also reduces life expectancy and lowers the quality of life.
Thus, weight loss is critical in managing obesity and improving overall health.
Losing weight can be challenging, but it is essential for reducing the risk of developing obesity-related health problems. While significant weight loss can be achieved through a combination of lifestyle changes, such as healthy eating, regular exercise, and stress management, medical interventions can sometimes be necessary.
Let’s take a closer look.
Weight Loss Management At Ellevate Med Spa
Weight loss is a common goal for many individuals, but achieving and maintaining it can be challenging. For this reason, weight loss management programs here at Ellevate Med Spa have become increasingly popular.
So far, there are two medications that have shown promising results in helping individuals achieve -and maintain- significant weight loss. They are Semaglutide and Terzepatide.
All About Semaglutide and Terzepatide
Semaglutide and Terzepatide are both injectable medications that work by mimicking the action of a hormone called GLP-1, which reduces appetite and increases feelings of fullness. In clinical trials, both medications have shown significant weight loss results, with some participants losing up to 15% of their body weight.
These medications are typically prescribed alongside a healthy diet and exercise regimen and are usually administered once a week.
Ozempic, Wegovy, and Mounjaro are basically top brands for Semaglutide and Terzepatide. In fact, they all belong to the same class of drugs called GLP-1 receptor agonists. Ozempic and Wegovy contain Semaglutide as their active ingredient, while Mounjaro contains Terzepatide.
Like Semaglutide and Terzepatide, Ozempic, and Wegovy have been shown to be effective in significantly reducing body weight in clinical trials. Ozempic is typically prescribed for the treatment of Type 2 diabetes, but it is also approved for use as a weight loss medication.
Wegovy, on the other hand, was specifically approved by the FDA as a weight loss medication.
Mounjaro, which is the newest medication in this class, is still in clinical trials. However, early results have shown that it may be even more effective than Semaglutide and Terzepatide in promoting weight loss. Like Semaglutide and Terzepatide, Mounjaro is administered via weekly injections.
It is crucial to understand the importance of weight loss management for preventing and managing obesity. With the right approach and support, individuals can successfully achieve their weight loss goals – and improve their health and well-being.
If you are struggling with weight issues, visit us here at Ellevate Med Spa in Chelmsford, MA. Our experienced providers will help you arrive -and stay at – a healthy weight with the approach that matches your specific concerns and goals.
Call us now and schedule your appointment today.